Could the erythrocyte indices or serum ferritin predict the therapeutic response to a trial with oral iron during pregnancy? Results from the Accuracy study for Maternal Anaemia diagnosis (AMA)

Bresani Salvi, Cristiane Campello; Braga, Maria Cynthia; Figueirôa, José Natal; Batista Filho, Malaquias

Article

Registro en:

BRESANI SALVI, C. C. et al. Could the erythrocyte indices or serum ferritin predict the therapeutic response to a trial with oral iron during pregnancy? Results from the Accuracy study for Maternal Anaemia diagnosis (AMA). BMC Pregnancy and Childbirth, v. 16, n. 1, p. 1-10, Dec. 2016.

1471-2393

https://www.arca.fiocruz.br/handle/icict/19300

10.1186/s12884-016-1005-x

https://repositorioslatinoamericanos.uchile.cl/handle/2250/8868500

Autor

Bresani Salvi, Cristiane Campello

Braga, Maria Cynthia

Figueirôa, José Natal

Batista Filho, Malaquias

Institución

Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Brasil)

Resumen

Treatment of maternal iron-deficiency anaemia can reduce risks of prematurity and low birth weight; hence a reliable diagnosis of maternal iron needs is critical. However, erythrocyte indices and serum ferritin have shown a weak correlation with iron status during pregnancy. This study verified the accuracy of those tests to predict the responsiveness to a therapeutic test with oral iron as reference standard for iron deficiency in pregnant women.